What's Happening?
Osita Chidoka, a former Aviation Minister and Chancellor of the Athena Centre for Policy and Leadership, has called on Nigerian pharmaceutical manufacturers to move beyond basic compliance with local regulations and align with international standards.
Speaking at the 29th national conference of the Association of Industrial Pharmacists of Nigeria in Ilorin, Chidoka emphasized the need for the industry to adopt global quality standards to improve Nigeria's health security and industrial competitiveness. He highlighted the heavy reliance on imported Active Pharmaceutical Ingredients (APIs), which constitutes 70-80% of the industry's needs, as a significant structural weakness. Chidoka pointed out that the high cost of medicines in Nigeria, compared to their international market value, exacerbates the financial burden on Nigerian consumers. He urged manufacturers to treat regulatory compliance as a strategic tool for gaining international market access, particularly under the African Continental Free Trade Area framework.
Why It's Important?
The call for Nigerian pharmaceutical manufacturers to adopt global standards is crucial for several reasons. Aligning with international standards can enhance the quality of pharmaceutical products, making them more competitive in the global market. This shift could lead to increased export opportunities and reduce the industry's dependency on imported APIs, thereby strengthening Nigeria's economic resilience. Moreover, by improving product quality and operational efficiency, the industry can better serve the Nigerian consumer, potentially lowering the cost of medicines and improving access to healthcare. This move could also position Nigeria as a key player in the African Continental Free Trade Area, fostering economic growth and development.
What's Next?
If Nigerian pharmaceutical manufacturers heed Chidoka's advice, the industry may see a transformation in its operational practices. Companies might begin to invest in quality assurance and modern performance management systems to enhance productivity. This could lead to increased collaboration with international regulatory bodies like the World Health Organisation and the U.S. Food and Drug Administration. Additionally, the Nigerian government and industry stakeholders may need to provide support and incentives to facilitate this transition, ensuring that manufacturers have the resources and guidance needed to meet global standards.
